Capravirine

This classification denotes a reverse transcriptase inhibitor with the molecular formula C20H20Cl2N4O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier VHC779598X, chemically known as 5-(3,5-dichlorophenyl)thio-4-isopropyl-1-(pyridin-4-yl-methyl)-1h-imidazol-2-yl-methyl carbamate but generally known as capravirine, which bears US NIH Compound Identifier 1783. European Medicines Agency schedules Capravirine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB20328. The term CAPRAVIRINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 15 No. 1, 2001, List 45). Most nations schedule capravirine under HS 29333999 and SITC 51574. As of Q4 2014, CAPRAVIRINE remains the US FDA Preferred Term for this commodity. Capravirine bears US NLM identifiers UMLS ID C0755617 and NCI Concept Code C81612. SMILES: Clc1cc(Sc2n(c(nc2C(C)C)COC(=O)N)Cc2ccncc2)cc(Cl)c1.